CLINICAL RESEARCH
Local Release of C-Reactive Protein From Vulnerable Plaque or Coronary Arterial Wall Injured by Stenting
Teruo Inoue, MD, FACC*,*,
Toru Kato, MD*,
Toshihiko Uchida, MD ,
Masashi Sakuma, MD ,
Atsuko Nakajima, BSc ,
Mitsuei Shibazaki, BSc ,
Yoshitaka Imoto, BSc ,
Masahiko Saito, MD||,
Shigemasa Hashimoto, MD*,
Yutaka Hikichi, MD* and
Koichi Node, MD*
*Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine, Saga, Japan
Department of Cardiology, Koshigaya Hospital, Dokkyo University School of Medicine, Koshigaya, Japan
Department of Laboratory Medicine, Dokkyo University School of Medicine, Koshigaya, Japan
Yufu Itonaga Co. Ltd., Tokyo, Japan
|| Department of Cardiology, Cardiovascular Center, Ageo Central General Hospital, Ageo, Japan
Manuscript received August 27, 2004;
revised manuscript received March 24, 2005,
accepted April 14, 2005.
* Reprint requests and correspondence: Dr. Teruo Inoue, Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine, 5-1-1 Nabeshima, Saga 849-8501, Japan
(Email: inouete{at}med.saga-u.ac.jp).
OBJECTIVES: The purpose of this study was to assess local release of C-reactive protein (CRP) from atherosclerotic plaques or the vessel wall injured by stenting.
BACKGROUND: Recent research has focused on the local production of CRP, especially in inflammatory atherosclerotic plaques.
METHODS: The study consisted of two separate protocols. In protocol 1, we measured serum high-sensitivity-CRP (hs-CRP) levels in coronary arterial blood sampled just distal and proximal to the culprit lesions in 36 patients with stable angina and 13 patients with unstable angina. In protocol 2, we measured serial serum hs-CRP levels and activated Mac-1 on the surface of neutrophils in both coronary sinus and peripheral blood in 20 patients undergoing coronary stenting.
RESULTS: In protocol 1, CRP was higher in distal blood than proximal blood in both stable (p < 0.05) and unstable angina (p < 0.01). The translesional CRP gradient (distal CRP minus proximal CRP, p < 0.05) as well as the proximal CRP (p < 0.05) and distal CRP (p < 0.05) was higher in unstable angina than in stable angina. In protocol 2, the transcardiac CRP gradient (coronary sinus minus peripheral blood) and activated Mac-1 increased gradually after stenting, reaching a maximum at 48 h (p < 0.001 vs. baseline for both). There was a positive correlation between the transcardiac CRP gradient and activated Mac-1 at 48 h (r = 0.45, p < 0.01).
CONCLUSIONS: C-reactive protein is an excellent marker for plaque instability or poststent inflammatory status, and its source might be the inflammation site of the plaque or the coronary arterial wall injured by stenting.
|
Abbreviations and Acronyms
| | ACS = acute coronary symptoms | | CRP = C-reactive protein | | EDTA = ethylenediaminetetraacetic acid | | hs-CRP = high-sensitivity C-reactive protein | | MLD = minimal lumen diameter | | PCI = percutaneous coronary intervention |
|
This article has been cited by other articles:

|
 |

|
 |
 
F. Montecucco, S. Steffens, F. Burger, G. Pelli, C. Monaco, and F. Mach
C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes
J. Leukoc. Biol.,
October 1, 2008;
84(4):
1109 - 1119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Miyamoto, M Ueda, M Ikemoto, T Naruko, A Itoh, S Tamaki, R Nohara, F Terasaki, S Sasayama, and M Fujita
Increased serum levels and expression of S100A8/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina
Heart,
August 1, 2008;
94(8):
1002 - 1007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-W. Park, C. W. Lee, S.-C. Yun, Y.-H. Kim, M.-K. Hong, J.-J. Kim, S.-W. Park, and S.-J. Park
Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation
Heart,
September 1, 2007;
93(9):
1087 - 1092.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Momin, N. Melikian, S. B. Wheatcroft, D. Grieve, L. C. John, A. El Gamel, M. T. Marrinan, J. B. Desai, C. Driver, R. Sherwood, et al.
The association between saphenous vein endothelial function, systemic inflammation, and statin therapy in patients undergoing coronary artery bypass surgery
J. Thorac. Cardiovasc. Surg.,
August 1, 2007;
134(2):
335 - 341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Grad, M. Golomb, I. Mor-Yosef, N. Koroukhov, C. Lotan, E. R. Edelman, and H. D. Danenberg
Transgenic expression of human C-reactive protein suppresses endothelial nitric oxide synthase expression and bioactivity after vascular injury
Am J Physiol Heart Circ Physiol,
July 1, 2007;
293(1):
H489 - H495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Marsik, R. Sunder-Plassmann, B. Jilma, F. M. Kovar, C. Mannhalter, O. Wagner, H. Rumpold, and G. Endler
The C-Reactive Protein +1444C/T Alteration Modulates the Inflammation and Coagulation Response in Human Endotoxemia
Clin. Chem.,
October 1, 2006;
52(10):
1952 - 1957.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Doronzo, I. Russo, M. Trovati, and G. Anfossi
Sodium azide in commercially available C-reactive protein preparations does not influence matrix metalloproteinase-2 synthesis and release in cultured human aortic vascular smooth muscle cells.
Clin. Chem.,
June 1, 2006;
52(6):
1200 - 1201.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Scirica, D. A. Morrow, S. Verma, S. Devaraj, I. Jialal, B. M. Scirica, D. A. Morrow, S. Verma, S. Devaraj, and I. Jialal
The Verdict Is Still Out
Circulation,
May 2, 2006;
113(17):
2128 - 2151.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Krupinski, M. M. Turu, J. Martinez-Gonzalez, A. Carvajal, J. O. Juan-Babot, E. Iborra, M. Slevin, F. Rubio, and L. Badimon
Endogenous Expression of C-Reactive Protein Is Increased in Active (Ulcerated Noncomplicated) Human Carotid Artery Plaques
Stroke,
May 1, 2006;
37(5):
1200 - 1204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Y. Tiong and D. Brieger
Release of C-Reactive Protein by Stenting
J. Am. Coll. Cardiol.,
April 18, 2006;
47(8):
1733 - 1734.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Inoue, T. Kato, T. Uchida, M. Sakuma, A. Nakajima, M. Shibazaki, Y. Imoto, M. Saito, S. Hashimoto, Y. Hikichi, et al.
Reply
J. Am. Coll. Cardiol.,
April 18, 2006;
47(8):
1734 - 1734.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Jialal, S. Devaraj, and U. Singh
C-Reactive Protein and the Vascular Endothelium: Implications for Plaque Instability
J. Am. Coll. Cardiol.,
April 4, 2006;
47(7):
1379 - 1381.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Jialal, S. Devaraj, U. Singh, J. Fan, and Y. E. Chen
Sources of CRP in Atherosclerotic Lesions
Am. J. Pathol.,
March 1, 2006;
168(3):
1054 - 1056.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, D. Sahn, and S. Tsimikas
Highlights of the Year in JACC 2005
J. Am. Coll. Cardiol.,
January 3, 2006;
47(1):
184 - 202.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Dubinsky
Coronary Artery Calcification Scoring
Am. J. Roentgenol.,
December 1, 2005;
185(6):
1540 - 1541.
[Full Text]
[PDF]
|
 |
|
|